Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 871.30
-9.10 (-1.03%)
Jun 5, 2025, 5:24 PM IDT
Epitomee Medical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
42
Market Cap
260.08M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| Novolog (Pharm-Up 1966) | 2.07B |
| BrainsWay | 161.81M |
| Ilex Medical | 922.08M |